Şenol, KazımFerhatoğlu, Murat FerhatKocaeli, Aysen AkkurtDündar, Halit ZiyaKaya, Ekrem2024-06-112024-06-112021-03-012168-023Xhttps://doi.org/10.1089/bari.2020.0110https://hdl.handle.net/11452/42003https://www.liebertpub.com/doi/10.1089/bari.2020.0110Objective: To prospectively evaluate the postoperative morbidity, mortality, and weight loss evolution of patients who underwent a bariatric procedure during 1 year of follow-up.Methods: Since July 2016, a total of 101 patients' data have been prospectively registered in a database. Comorbidities, operating time, hospital stay, early and late complications rate, and weight loss evolution after 1 year of follow-up were recorded.Results: The mean age was 38.41 +/- 11.05 years with a mean body mass index (BMI) of 49.02 +/- 5.89 kg/m(2) (range 38-67). Laparoscopic sleeve gastrectomy (LSG) was performed in 93 patients (92.07%) and Roux-en-Y gastric bypass (RNYGB) in 8 patients (7.92%). Thirty-day morbidity rate was 7.92% (8/101). Within a mean 9.32 +/- 2.25 (range 1-19) months follow-up time, mean percent of the excess of weight loss of 1st, 6th, and 12th months were 22.7 +/- 6.1, 67.2 +/- 11.2, and 81.4 +/- 10.5, respectively. Diabetes (n = 38, 37.6%), hypertension (n = 13, 12.9%), and obstructive sleep apnea (n = 5, 4.9%) were resolved in 76%, 68.4%, and 100% of the patients, respectively (p < 0.001).Conclusions: LSG and RNYGB are safe and highly effective, particularly in patients with a BMI >50 kg/m(2). Both techniques have been presented with better clinical outcomes regarding significant comorbidity resolution in the early evolution of weight loss.eninfo:eu-repo/semantics/openAccessLaparoscopic-sleeve-gastrectomyY gastric bypassWeight-lossComplicationsObesityRural surgeryComorbidity resolutionScience & technologyLife sciences & biomedicineNursingSurgeryArticle000629728000011616716110.1089/bari.2020.01102168-0248